Loop Diuretics: Site of Action and Mechanism
Loop diuretics act on the thick ascending limb of the loop of Henle by blocking the Na⁺/K⁺/2Cl⁻ cotransporter, and they do NOT exchange sodium for potassium—instead, they indirectly increase potassium loss through downstream effects in the distal tubule. 1, 2
Primary Site and Mechanism of Action
Loop diuretics (furosemide, bumetanide, torsemide, piretanide) work specifically in the thick ascending limb of the loop of Henle, where they reversibly bind to the Na⁺/K⁺/2Cl⁻ cotransporter located in the luminal membrane. 1, 3
- This cotransporter normally mediates NaCl reabsorption by moving one sodium, two chloride, and one potassium ion together into the cell. 4
- By blocking this transporter, loop diuretics reduce or abolish NaCl reabsorption at this site, which accounts for their potent diuretic effect. 1, 2
- The inhibition of this transporter decreases medullary interstitial hypertonicity, which subsequently reduces water reabsorption in the collecting duct. 1
Potassium Loss Mechanism: Indirect, Not Direct Exchange
Loop diuretics do NOT directly exchange sodium for potassium. The potassium wasting occurs through two distinct mechanisms:
Distal Tubule Effects
- Loop diuretics sharply increase the delivery of fluid, sodium, and water to the distal tubule. 5
- This increased distal delivery stimulates potassium secretion in the distal tubule and collecting duct, where sodium reabsorption is coupled with potassium secretion. 5
- The enhanced flow rate and increased sodium availability in the distal nephron drive increased potassium excretion. 1
Reduced Loop Reabsorption
- Under normal conditions, some potassium reabsorption occurs in the thick ascending limb itself. 2
- Loop diuretics reduce this reabsorption, contributing to net potassium loss. 2
Additional Effects Beyond Sodium and Potassium
Loop diuretics also affect other electrolytes in the thick ascending limb:
- They reduce calcium and magnesium reabsorption, though the exact mechanism remains unclear. 1, 2
- They increase urinary acid and ammonium excretion by effects in both the loop of Henle and distal tubule. 5
- They dramatically reduce oxygen consumption and substrate requirements in thick ascending limb cells by decreasing active transport work. 1, 2
Clinical Implications for Potassium Management
The Mayo Clinic emphasizes that even with torsemide's relatively potassium-sparing properties compared to other loop diuretics, electrolyte surveillance remains essential in high-risk groups including advanced CKD, concurrent RAAS inhibitor use, and diabetes. 6
- If hypokalemia develops, the American College of Cardiology recommends adding a potassium-sparing diuretic like spironolactone rather than discontinuing the loop diuretic, particularly in heart failure patients requiring guideline-directed medical therapy. 6
- Potassium-sparing diuretics (amiloride, triamterene) can suppress the kaliuresis induced by loop diuretics when given concurrently. 5